The study examined 833 site visits conducted over a six-year period over seven specialized ACS accreditation and verification programs. These programs include the Commission on Cancer (CoC), National Accreditation Program for Breast Centers (NAPBC), National Accreditation Program for Rectal Cancer (NAPRC), Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), Trauma Verification, Review, and Consultation Program (VRC), Children’s Surgery Verification (CSV), and Geriatric Surgery Verification (GSV). Collectively, these initiatives provide a comprehensive framework designed to address the quality dimensions of complex surgical care within diverse patient populations and hospital settings.

Crucially, the research reveals that only 61% of hospitals achieved accreditation upon their first assessment, highlighting both the challenging nature of ACS standards and the variability among programs. For instance, first-pass success rates ranged widely, with only about 31% of hospitals passing the stringent NAPRC and Children’s Surgery Verification programs on their initial evaluation. In contrast, the Metabolic and Bariatric Surgery program (MBSAQIP) witnessed a notably higher initial success rate of 86%, reflecting disparities in institutional preparedness or program-specific criteria stringency.

Among the deficient areas identified, the most common pitfalls centered around staffing adequacy and clinical care protocols. The study pinpoints two specific domains—“Personnel and Services Resources” and “Patient Care: Expectations and Protocols”—as recurrent trouble spots. These findings suggest that beyond advanced technical capabilities, human resource allocation and adherence to evidence-based process standards remain critical barriers to optimal surgical care delivery, underscoring the multifaceted nature of quality improvement.

Importantly, for hospitals that did not pass on their first attempt, the accreditation journey demonstrated remarkable efficacy. Of the 267 sites reevaluated during the study window, 80% eventually attained accreditation. When excluding institutions that withdrew or discontinued the process, this "second-chance" success rate rose dramatically to 94%. This observation vividly illustrates that ACS accreditation functions not merely as a certification mechanism but as a structured, iterative quality-improvement pathway that actively supports hospitals in overcoming deficiencies.

Dr. Brett Johnson, the study’s lead author and a surgical resident at Baylor University Medical Center, emphasized that accreditation should be understood as a true quality filter rather than a perfunctory checklist. His team’s work confirms that although ACS standards maintain high entry thresholds—causing an initial 40% failure rate—the remediation and review process embedded in the accreditation cycle fosters measurable institutional progress. This dual role positions ACS Quality Programs as integral components of systemic surgical care advancement.

The methodology underlying the accreditation process involves rigorous peer review by multidisciplinary teams who conduct on-site evaluations assessing compliance with evidence-based clinical standards. The ACS framework engenders a culture of accountability through external validation, challenging hospitals to critically assess and enhance their practices. Previous literature correlates ACS accreditation with improved surgical outcomes, including reduced complications and enhanced survival, lending empirical support to these evaluative standards as drivers of patient benefit.

ACS accreditation encompasses nine overarching quality domains that collectively guide hospitals toward comprehensive surgical excellence. While individual program requirements vary to address the nuances of specific patient populations and surgical procedures, common emphases include institutional leadership commitment, multidisciplinary engagement, quality improvement infrastructure, and data-driven performance monitoring. These factors collectively foster a robust ecosystem conducive to sustained quality enhancement within surgical services.

Looking forward, the study identifies three pivotal avenues for future research: first, investigating how accreditation impacts concrete patient outcomes such as morbidity, mortality, and complication rates; second, tracking sustained compliance post-accreditation to understand long-term adherence and performance; and third, analyzing systemic obstacles that hinder wider adoption of ACS accreditation among hospitals nationwide. Addressing these questions could further refine accreditation efficacy and expand its reach to improve surgical care universally.

Senior study author Dr. Clifford Y. Ko, director of Quality Programs at the ACS, remarked upon the transformative potential of these findings. They illustrate that participation in ACS Quality Programs provides a valuable, structured journey toward surgical excellence. Regardless of a hospital’s starting point on the quality spectrum, engagement in accreditation facilitates continuous improvement, reinforcing ACS’s mission to foster highest standards in surgical practice.

This landmark analysis now sets a precedent for transparency and accountability in healthcare quality assessment. By quantifying initial pass rates and delineating barriers to success, the study charts a practical roadmap for hospitals aiming to meet and exceed national standards. It confirms that accreditation is not merely recognition of current achievement but an active force in shaping future surgical care quality.

In an era of escalating demands for healthcare quality and patient safety, this research underscores the indispensable role of independent, evidence-based accreditation processes. As healthcare systems strive for excellence under increasing scrutiny, the ACS model provides an effective blueprint linking rigorous standards, external verification, and supportive remediation to tangible enhancements in patient care.

With more than 2,300 hospitals currently engaged in various ACS Quality Programs, the scope and impact of accreditation are poised to grow. This study’s insights serve as a clarion call for healthcare institutions and policymakers to embrace structured accreditation not only as a badge of honor but as a pragmatic strategy for continuous quality development, ultimately advancing the state of American surgical care.

Subject of Research: Evaluation of initial hospital site visit pass rates for accreditation across American College of Surgeons Quality Programs.

Article Title: Evaluating Initial Site Visit Pass Rates Across American College of Surgeons Accreditation Programs

News Publication Date: 11 June 2025

Web References:

• American College of Surgeons
• DOI link to article

References: See references 4–8 in the original study publication for detailed prior literature.

Keywords: Surgery, Health care delivery, Hospitals, Traumatic injury, Cancer

The investigation, articulated in the jointly authored paper titled "Private Equity in the Hospital Industry," integrates data from over 1,200 hospital acquisitions across the United States between 2001 and 2018. By employing advanced econometric methodologies and comprehensive insurance claims data, the research team, including Merih Sevilir of ESMT and IWH, Janet Gao of Georgetown University, and Yongseok Kim of Tulane University, delivers one of the most exhaustive empirical studies to date on how PE involvement impacts hospital operations, pricing strategies, staffing, and clinical outcomes.

A principal revelation from the study centers on the operational profitability of hospitals post-acquisition. Despite concerns that private equity might prioritize cost-cutting at the expense of essential services, the findings indicate that these hospitals not only stabilize financially but also sustain vital medical personnel over the long term. Cost reductions are principally driven by restructuring administrative functions, with a pronounced 33 percent reduction in administrative staff for hospitals formerly organized as non-profit entities. This nuanced cost containment approach highlights the capacity of PE ownership to reengineer institutions traditionally insulated from market pressures.

Critically, the research dispels the notion that private equity blunts access to healthcare through increased hospital closures. Comprehensive survival analysis reveals no statistically significant rise in closure rates among PE-owned hospitals compared to non-PE counterparts. This underscores that private equity, rather than dismantling healthcare infrastructure, may bolster certain operational dynamics that enhance institutional resilience.

Digging deeper into staffing implications, the study illustrates a strategic differentiation between clinical and non-clinical personnel adjustments. While administrative staff reductions were prominent, the number of core medical professionals remained intact or even slightly increased. This pattern suggests deliberate preservation of clinical capacity essential to maintaining patient care standards, even amid ownership transitions.

Another critical dimension explored involves pricing and patient demographics. Contrary to assertions that private equity firms might raise inpatient prices to maximize profits or preferentially admit younger, wealthier, or healthier patients, the research finds no significant evidence supporting such shifts. Pricing trends remain stable post-acquisition, and demographic profiles of treated patients do not statistically deviate, ensuring that equity in care access is largely preserved under PE stewardship.

Clinical outcomes, arguably the paramount metric for evaluating healthcare quality, also exhibit reassuring stability. Mortality rates, readmission frequencies, and other health outcome indicators show no meaningful deterioration under PE ownership. This empirical validation rebuts fears that privatization intrinsically endangers patient well-being and indicates that efficiency enhancements need not trade-off with clinical excellence.

Nonetheless, the study acknowledges a subtle yet noteworthy downside: a discernible decline in patient satisfaction levels following private equity acquisition. This decrease is hypothesized to stem from administrative streamlining, which may indirectly erode non-clinical patient support services such as scheduling, customer service, and facility management. While core medical services remain robust, the patient experience in ancillary domains could face challenges warranting further investigation.

From a theoretical standpoint, this research advances our understanding of how market mechanisms interact with public goods like healthcare. Private equity’s introduction into historically non-market-driven hospitals triggers a recalibration of managerial oversight and operational efficiencies without eroding essential care components. These dynamics showcase the potential for hybrid ownership models to reconcile profitability with public health imperatives.

The authors emphasize that their findings carry significant policy implications. Public fears of PE as predatory participants in healthcare can be tempered by data demonstrating their role in streamlining administrative inefficiencies and safeguarding clinical functions. Regulators may consider these insights when designing frameworks that balance investor incentives with quality assurance and equitable access.

Methodologically, the study leverages a rich dataset of insurance claims, enabling high-resolution analysis of patient demographics, pricing patterns, clinical outcomes, and employment changes pre- and post-acquisition. By integrating multiple data sources and applying rigorous statistical techniques to control for confounders, the research achieves robustness and generalizability rarely attained in health economics.

In sum, this seminal study redefines the discourse on private equity’s role in healthcare. It portrays PE investments as catalysts for operational enhancement rather than dismantling forces, particularly highlighting their impact in nonprofit hospital sectors through targeted reductions in administrative overhead. While patient satisfaction requires attention, the overall evidence supports a more nuanced view of private equity as a constructive agent in hospital management.

The paper has been accepted for publication in the Journal of Financial Economics, signifying its contribution to the academic literature on financial markets and healthcare. Its multidisciplinary approach, combining economics, finance, and health services research, opens pathways for future investigations into ownership structures and healthcare delivery optimization.

Ultimately, this research invites stakeholders—policymakers, investors, healthcare providers, and the general public—to reconsider assumptions about private equity in hospitals. Through meticulously analyzed data and careful interpretation, it becomes clear that private equity can enhance efficiency without compromising care integrity, offering a viable paradigm for future healthcare system reforms.

Subject of Research: Not applicable

Article Title: Private Equity in the Hospital Industry

Web References:

• https://esmt.berlin/person/merih-sevilir
• https://gufaculty360.georgetown.edu/s/contact/0031Q00002bh6vrQAA/janet-gao
• https://freeman.tulane.edu/faculty-research/finance/yongseok-kim
• https://www.jfinec.com/

Image Credits: Credit: IWH

Keywords: Medical facilities, Health care, Medical economics